ProImmune - Mastering Immunity | MHC pentamers, CD1d tetramers, custom peptide synthesis, immunoassays, T cell epitope discovery, HLA tissue typing, cellular analysis, ligand binding assays, immune response

Mastering Immunity

ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. Our unique innovative solutions for preclinical and clinical immunology research help you take your studies to success through responsive service and focused application support, saving you time and money and reducing risk.

Our Story     Our Clients


Request a Quote

Subscribe to Email Newsletters


USA/Canada Toll free: + 1 888 505 7765

All other countries: + 44 870 042 7279


Conference Video

Mastering Immunogenicity 2014

Dr Timothy Hickling

Pfizer, Inc.

Contribution of ex vivo assays to immunogenicity risk assessment

Prof Herman Waldmann

University of Oxford

Tolerance can be induced in the adult immune system

Prof Arlene Sharpe

Harvard University

T Cell Co-Inhibitory Pathways & Cancer Immunotherapy Roles

Dr Susan Kirshner


Therapeutic Proteins: Route of exposure and immunogenicity risk

Watch More Content


Pro5® MHC Pentamers for T Cell detection

CD1d Tetramers for NKT Cell detection

ProMix™ Immunodominant Peptide Pools

thinkpeptides®: Custom Peptide Synthesis

Services (by application)

Immunogenicity in Drug Development


Antigen Characterization

Immune Monitoring

Services (by assay)

ProPresent® Antigen Presentation Assay

Naïve T Cell Proliferation Assays

DC-T Cell Proliferation Assays

MHC I Binding Assays

MHC II Binding Assays

New: MHC II Binding Competition Assays

Prostorm® Cytokine Release Assay

ELISPOT Assay Service

Flow Cytometry Assay Service

ProArray Ultra® Ligand Binding Assays

ProArray Ultra® B-Cell Epitope Mapping

typeHLA Tissue Typing Service

Special Assay Service



Latest News

Our 4th Mastering Immunogenicity conference in Boston, September 15-16 2014 had a stronger academic focus than ever before, highlighting new concepts that should be taken into account in managing immunogenicity risk.

Meet ProImmune at the following events before the end of 2014:

BioEurope, Frankfurt, Germany

Immunogenicity and Bioassay Summit, Bethesda Maryland

IBC Antibody Engineering & Therapeutics, Huntingdon Beach, California

Customer testimonials

Latest customer publications

Pro5® MHC Pentamers used in study published by scientists at Genentech to demonstrate that cross presentation is more efficient that direct presentation of influenza A virus

Figure from: Smed-Sörensen A, Chalouni C, Chatterjee B, Cohn L, et al. (2012) Influenza A Virus Infection of Human Primary Dendritic Cells Impairs Their Ability to Cross-Present Antigen to CD8 T Cells. PLoS Pathog 8(3): e1002572. doi:10.1371/journal.ppat.1002572




Product Information Sheets

Free Resources & Downloads

Peptides Information Poster

Peptides eBook

Pentamer Catalog Pentamer Handbook
Pro5® Pentamer catalog Pro5® Pentamer Handbook